Researchers led by Tanya Hutter at the University of Texas at Austin describe a mid‑infrared fiber probe that measures glucose, lactate and ethanol simultaneously. At just 1.1 millimetres in diameter, the probe aims to provide faster, minimally invasive metabolic monitoring for clinical and wellness uses.
The sensor contains two silver halide optical fibers housed in a PEEK tube and protected by a semi‑permeable membrane. One fiber has an angled tip to deliver and collect light; the second is gold‑coated to act as a mirror. The probe connects to a quantum cascade laser (QCL) that supplies mid‑infrared light. Each target molecule has a distinct spectral absorption, and measured absorption is proportional to concentration, giving a direct readout of biomarker levels while leaving the local tissue environment largely undisturbed.
Compared with microdialysis, which collects fluid samples for later lab analysis and can delay results in situations such as severe traumatic brain injury, the probe offers near‑real‑time data that could speed clinical decisions. The developers also note potential adaptation for wearable wellness monitoring. Discovery to Impact has filed a patent application that can be licensed to industry partners.
- Clinical uses: diabetes care, sepsis and brain injury monitoring
- Alcohol-related uses: intoxication, addiction care, organ injury assessment
- Wellness: energy use, performance and stress tracking
Difficult words
- probe — small medical instrument inserted into tissue
- minimally invasive — causing little damage or disturbance to body
- optical fiber — thin glass or plastic strand carrying lightoptical fibers
- quantum cascade laser — type of laser that emits mid‑infrared light
- absorption — process where a substance takes in energy
- microdialysis — technique collecting fluid samples for later analysis
- biomarker — biological substance indicating a physiological state
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Which clinical use listed in the article would benefit most from near-real-time metabolic monitoring, and why?
- What challenges might appear when adapting this probe for wearable wellness monitoring?
- How could licensing the patent application affect the probe's development and public availability?
Related articles
PAHO issues first guide for tungiasis treatment
PAHO has published the first evidence-based guide to treat tungiasis, recommending low-viscosity dimethicone and warning against unsafe manual removal. The disease affects millions in Latin America, the Caribbean and Sub-Saharan Africa.
Alzheimer’s tests may show different brain changes in women and men
A Georgia State University study finds common cognitive screens like the MMSE may not detect the same brain changes in women and men. The results suggest sex-aware interpretation of tests and further study of hormones and genetics.
Mpox may be spreading quietly in Nigeria
A study in Nigeria tested archived blood from healthy adults and found signs of hidden mpox exposure. Some people had old smallpox antibodies and a small number showed recent immune responses without symptoms, suggesting low-level virus circulation.
Gut has a backup system for IgA antibodies
Researchers found two different routes that make IgA antibodies in the gut. Early IgA often comes from non‑germinal center cells but later from germinal centers; both types showed similar specificity and mutations, which may help vaccine design.